
Specifically, a new tool for High Intensity Therapeutic Ultrasound (HITU) devices – a tissue-mimicking phantom – was recently qualified and can be used by device developers to test the safety of their device early in the development process – before beginning clinical trials – when it’s easier to make changes to improve the safety profile if necessary. This also streamlines the FDA process for device developers as it provides one standard method for the entire field to use.